Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity
NCT06214468Phase 1Completed
- Sponsor
- University of South Alabama
- Start
- Jan 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of nicotinamide riboside in Acetaminophen toxicity (2 arms), sponsored by University of South Alabama. Primary endpoints: Quantity of NAD(P)(H) at 6 hours, DNA Damage Count at 6 hours and 3 more. Started Jan 2024; status: completed.
02
Drugs
nicotinamide riboside
03
Conditions
Acetaminophen toxicity
Beyond the preview
Go deeper on NCT06214468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06214468.